The year 1979 was to prove a watershed in the history of osteogenesis imperfecta (01) with the publication by Sillence et all of a comprehensive classification embracing clinical, genetic, and radiological parameters. These authors identified "at least four distinct syndromes" falling within the spectrum of 01. Type I constituted the largest group of patients with autosomal dominant inheritance of osteoporosis, blue sclerae, deafness, and dentinogenesis imperfecta. Type II patients died in the perinatal period with crumpled femora and beaded ribs. Type III was characterised by severe, progressive deformity, while in type IV, patients showed dominant inheritance of osteoporosis leading to fractures but with normal sclerae.
In their original study, Sillence et If the abnormal gene product is synthesised and incorporated into the type I procollagen molecule, thus preventing normal folding into a triple helix, then since each trimer contains two pro al(I) chairs on average three out of every four molecules will contain at least one abnormal chain resulting in degradation, a concept described as 'protein suicide'.1' Perhaps more apt are the terms 'included mutants' and 'excluded mutants' coined by Sykes.'2 Included mutants will be more deleterious than mutant chains which are so abnormal that synthesis or secretion or both are prevented, that is, excluded mutants. The mechanism explains how a new dominant mutation in one al(I) gene Prenatal diagnosis was achieved using routine obstetric ultrasonography for four of the cases in this study. The x ray of one of these babies is shown in fig 3, 
